Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Brassica Protection Products develops and commercializes glucoraphanin-rich ingredients derived from broccoli seeds using proprietary extraction technology. Their main product, TrueBroc® glucoraphanin, is used in dietary supplements, functional foods/beverages, teas, and coffees. The company has a long-standing collaboration with Johns Hopkins University to advance research on glucoraphanin/sulforaphane’s health benefits. They hold patents related to the prevention/treatment of oxidative stress disorders by modulating glutathione and phase II detoxification enzymes. No pharmaceutical drug pipeline or clinical trial programs are reported; their products are marketed as nutritional ingredients with substantiated scientific backing rather than regulated therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Brassica Protection Products.